The abnormal C-terminus in DVL1 impacts Robinow Syndrome phenotypes

This study demonstrates that the novel C-terminus created by frameshift mutations in DVL1 causes Robinow Syndrome by exerting a dominant-negative effect that mislocalizes the protein to the nucleus, thereby disrupting WNT signaling and craniofacial development.

The Gist

The Big Picture: A Broken Instruction Manual

Imagine your body is a massive construction site building a human baby. To build the face and limbs correctly, the construction crew follows a set of blueprints called the WNT signaling pathway. Think of this pathway as the "foreman" giving orders to the workers.

One of the most important foremen is a protein called DVL1. Its job is to make sure the workers know exactly where to build the nose, the jaw, and the limbs.

Robinow Syndrome is a rare condition where babies are born with a "wide face," a broad nose, and short limbs. Scientists knew this was caused by a broken DVL1 gene, but they didn't know why. Was the foreman missing? Was he shouting the wrong orders? Or was he holding a megaphone that was jamming the whole construction site?

This paper answers that question.

---

The Mystery: The "Bad Tail"

The DVL1 protein looks like a long rope with three distinct knots (functional domains) and a tail at the end.

• The Knots: These are the tools the protein uses to do its job.
• The Tail: This is the C-terminus. It's supposed to be a specific, neat length.

In people with Robinow Syndrome, a tiny typo in their DNA causes the "tail" of the DVL1 rope to get chopped off and replaced with a weird, new, jumbled tail.

Scientists had two theories:

1. Theory A (The Loss): The problem is that the original tail is missing. Without the original tail, the protein can't work.
2. Theory B (The Gain): The problem is the new, weird tail. This new tail is actively messing things up, like a rogue worker tripping everyone else.

The Experiment: Testing the Theories

The researchers decided to test these theories using two different "construction sites":

1. Chicken Embryos: They injected viruses into developing chicken faces to see if the beak would grow correctly.
2. Fruit Flies: They used fruit flies to see if their wings and legs would grow correctly.

They created three versions of the DVL1 protein to test:

• Version 1 (The Normal): The perfect, healthy foreman.
• Version 2 (The Truncated): The foreman with the original tail chopped off, but no new weird tail. (This tests Theory A).
• Version 3 (The Mutant): The foreman with the original tail chopped off and replaced with the weird, new tail found in Robinow patients. (This tests Theory B).

The Results: It's the "Weird Tail" That's the Problem

1. The Chicken Beak Test

• Normal Foreman: The chicken grew a normal beak.
• Truncated Foreman (No tail): The chicken grew a normal beak. The construction site ran fine even without the original tail!
• Mutant Foreman (Weird tail): The chicken grew a short, crooked, and wide beak. The construction site was a disaster.

2. The Fruit Fly Test

• Normal Foreman: Flies had straight wings with hairs pointing the right way.
• Truncated Foreman: Flies had normal wings.
• Mutant Foreman: Flies had twisted wings, extra bristles, and weird veins. The "weird tail" caused chaos.

The Verdict: The problem isn't that the original tail is missing. The problem is that the new, weird tail is actively sabotaging the construction. It's a "dominant interference." It's like a foreman who shows up with a megaphone that plays static noise, confusing all the other workers and stopping the building process.

How Does the Sabotage Happen?

The researchers found two main ways this "weird tail" ruins the day:

1. It Gets Lost in the Wrong Room
Normally, the DVL1 protein shuttles back and forth between the "office" (the nucleus) and the "workshop" (the cytoplasm) to deliver messages.

• The Normal Protein: Stays mostly in the workshop where it belongs.
• The Mutant Protein: Because of the weird tail, it gets stuck in the office (nucleus). It's like a foreman who is locked in the manager's office and can't get out to talk to the workers. This stops the signals from getting through.

2. It Breaks the Blueprint
The weird tail stops the protein from doing its job properly.

• It weakens the "Canonical" signal (the main blueprint for building bones).
• It messes up the "Non-Canonical" signal (the blueprint for cell shape and movement).
• Result: The cells don't know how to turn into cartilage (the soft tissue that becomes bone). In the chicken, the nose cartilage failed to form properly, leading to the wide, flat face seen in Robinow Syndrome.

The Takeaway

This study solves a long-standing mystery. Robinow Syndrome isn't caused by a "broken" protein that just stops working. It is caused by a mutant protein that actively interferes with the healthy proteins.

The "weird tail" acts like a glitch in the system that:

1. Traps the protein in the wrong place.
2. Confuses the construction crew.
3. Stops the face and limbs from growing correctly.

In simple terms: The body isn't just missing a part; it's being held hostage by a faulty part that refuses to let the good parts do their job. Understanding this helps scientists figure out how to fix the glitch in the future.

Technical Summary

1. Problem Statement

Robinow Syndrome (RS) is a rare, polygenic skeletal disorder characterized by craniofacial defects (e.g., hypertelorism, broad nasal bridge, jaw hypoplasia) and limb shortening. The autosomal dominant form is frequently caused by frameshift mutations in the DVL1 gene (Dishevelled 1), a key cytoplasmic adaptor in the WNT signaling pathway.

• The Specific Mechanism Unknown: All pathogenic DVL1 variants result in a frameshift near the C-terminus (specifically c.1519delT), replacing the native C-terminal amino acids with a novel, extended peptide sequence.
• The Central Question: It was unclear whether the RS phenotype is caused by:
  1. Loss-of-function: The absence of the native, conserved C-terminus.
  2. Gain-of-function/Neomorphic: The presence of the novel, abnormal C-terminal peptide causing dominant interference.
• Gap in Knowledge: Previous loss-of-function mouse models (heterozygous knockouts) did not recapitulate the RS phenotype, suggesting that simply losing DVL1 function is insufficient to explain the disease. The study aims to determine if the novel C-terminus is the driver of pathology.

2. Methodology

The authors employed a comparative approach using chicken embryos and Drosophila melanogaster to test three specific constructs of human DVL1:

1. wtDVL1: Wild-type human DVL1.
2. DVL1^1519ΔT: The pathogenic frameshift variant (c.1519delT) generating the novel C-terminal peptide.
3. DVL1¹⁵¹⁹:* A truncated version where a stop codon was introduced immediately after nucleotide 1519, removing the novel peptide but also the native C-terminus.

Experimental Models & Techniques:

• Chicken Embryo Model:
  • In Vivo: Avian retroviruses (RCAS) expressing the three constructs were injected into the frontonasal mass of stage 15 embryos (post-neural crest migration). Phenotypes were analyzed at stages 24, 29, and 38.
  • Assays: Whole-mount skeletal staining (Alcian Blue/Alizarin Red), histology, immunofluorescence (SOX9, TWIST, β-catenin, BrdU for proliferation, TUNEL for apoptosis), and qRT-PCR.
  • In Vitro: Primary micromass cultures of frontonasal mesenchyme were infected to assess chondrogenesis (cartilage formation) and gene expression (SOX9, COL2A1, TWIST2, MMP13, LEF1).
  • Signaling: Luciferase reporter assays (SuperTOPFlash for canonical WNT; ATF2 for non-canonical JNK/PCP) in facial mesenchyme.
• Drosophila Model:
  • Genetic Drivers: dpp-Gal4 (wing vein), hh-Gal4 (leg/wing disc), and ap-Gal4 (dorsal wing) were used to drive UAS-DVL1 constructs.
  • Assays: Analysis of adult wing morphology (hair polarity, vein thickening, ectopic bristles), larval wing disc immunostaining (puc-lacZ for JNK signaling, Armadillo/β-catenin for canonical WNT), and Western blotting for protein levels.
• Cell Biology:
  • Localization: HEK293T DVL Triple Knockout (TKO) cells were transfected with Flag-tagged constructs to visualize subcellular localization (cytoplasm vs. nucleus) via immunofluorescence.

3. Key Contributions

• Mechanistic Distinction: The study definitively separates the effects of losing the native C-terminus from the gain of the novel peptide.
• Dominant Interference: It establishes that the RS phenotype is driven by a neomorphic (gain-of-function) mechanism where the novel C-terminal peptide exerts dominant interference on normal development and signaling.
• Subcellular Localization: It identifies that the novel peptide causes mislocalization of DVL1 from the cytoplasm to the nucleus, likely due to the disruption of the Nuclear Export Sequence (NES).
• Context-Dependent Signaling: It reveals that the variant differentially affects canonical and non-canonical WNT pathways depending on the cellular context (vertebrate vs. invertebrate).

4. Key Results

A. Phenotypic Outcomes (Chicken & Fly)

• DVL1^1519ΔT (Pathogenic Variant):
  • Chicken: Caused severe upper beak shortening, deviation, and a widened frontonasal mass (mimicking hypertelorism/broad nasal bridge). It inhibited prenasal cartilage formation and reduced cell proliferation at stage 29.
  • Fly: Induced severe morphological defects, including wing creases, ectopic bristles, vein thickening, and lethality/eclosion failure in legs.
• DVL1¹⁵¹⁹ (Truncated, No Novel Peptide):*
  • Chicken: Phenotypically normal. Beak development, cartilage formation, and proliferation were indistinguishable from GFP controls.
  • Fly: Showed no morphological defects in wings or legs, despite expressing high levels of protein.
• Conclusion: The absence of the native C-terminus alone is not sufficient to cause RS; the presence of the novel peptide is the causative factor.

B. Cellular and Molecular Mechanisms

• Chondrogenesis: DVL1^1519ΔT significantly inhibited chondrogenesis in micromass cultures (reduced cartilage thickness and area) and downregulated chondrogenic markers (SOX9, COL2A1, TWIST2). DVL1^1519* retained some ability to support matrix secretion, unlike the variant.
• WNT Signaling:
  • Canonical (β-catenin): In chicken facial mesenchyme, DVL1^1519ΔT showed weak activation of the canonical pathway compared to wtDVL1. In Drosophila, it significantly reduced Armadillo (β-catenin) levels.
  • Non-Canonical (JNK/PCP): In Drosophila, DVL1^1519ΔT robustly induced JNK signaling (puc-lacZ and Mmp1 reporters), whereas wtDVL1 and DVL1^1519* did not.
• Protein Localization:
  • wtDVL1 & DVL1¹⁵¹⁹:* Primarily cytoplasmic with characteristic puncta.
  • DVL1^1519ΔT: Mislocalized to the nucleus. This suggests the novel peptide interferes with the Nuclear Export Sequence (NES) or alters protein conformation, trapping the protein in the nucleus.

5. Significance

• Pathogenesis Clarification: This is the first study to demonstrate that Robinow Syndrome caused by DVL1 frameshifts is a dominant-negative/neomorphic disorder driven by the novel C-terminal peptide, rather than a simple loss of function.
• Developmental Insight: The findings explain the specific craniofacial defects (wide face, short beak) as a failure of frontonasal mass narrowing and chondrogenesis due to the disruption of cell polarity and WNT signaling balance.
• Therapeutic Implications: Understanding that the novel peptide causes nuclear mislocalization and dominant interference suggests that therapeutic strategies should focus on preventing the formation or function of this aberrant peptide, rather than simply supplementing wild-type DVL1.
• Model Validation: The study validates the chicken and fly models as robust systems for dissecting the specific molecular consequences of human genetic variants, particularly for dominant skeletal disorders where mouse knockouts fail to phenocopy the disease.